小程序掃碼下單
本網(wǎng)站銷售的所有產(chǎn)品僅用于工業(yè)應(yīng)用或者科學(xué)研究等非醫(yī)療目的，不可用于人類或動(dòng)物的臨床診斷或者治療，非藥用，非食用。
Recombinant Human Insulin-like growth factor-binding protein 2, His (HEK-expressed)
英文名：
Cas號(hào)：
Cas號(hào)：
檢測(cè)信息查詢
| 貨號(hào) | 規(guī)格 | 貨期 | 庫(kù)存 | 價(jià)格 | 促銷價(jià) | 訂購(gòu) |
| 別 名 | |
| Cas號(hào) | |
| M D L | |
| 分子式 | |
| 分子量 | |
| 產(chǎn)品參數(shù) | |
| 性狀 | Recombinant Human Insulin-like growth factor-binding protein 2, His (HEK-expressed) 是高親和力結(jié)合蛋白家族成員 (IGFBP1-6)，在中樞神經(jīng)系統(tǒng)胰島素樣生長(zhǎng)因子 (IGF) 調(diào)控中發(fā)揮調(diào)控作用。
Synonyms rHuIGF-BP-2, His; IBP-2; IGFBP-2; BP2 ; 重組人胰島素樣生長(zhǎng)因子結(jié)合蛋白 2 His (HEK 細(xì)胞表達(dá)) Species Human Source HEK 293 Accession P18065 Gene ID 3485 Molecular Weight 6-20 kDa AA Sequence FRCPPCTPER LAACGPPPVA PPAAVAAVAG GARMPCAELV REPGCGCCSV CARLEGEACG VYTPRCGQGL RCYPHPGSEL PLQALVMGEG TCEKRRDAEY GASPEQVADN GDDHSEGGLV ENHVDSTMNM LGGGGSAGRK PLKSGMKELA VFREKVTEQH RQMGKGGKHH LGLEEPKKLR PPPARTPCQQ ELDQVLERIS TMRLPDERGP LEHLYSLHIP NCDKHGLYNL KQCKMSLNGQ RGECWCVNPN TGKLIQGAPT IRGDPECHLF YNEQQEARGV HTQRMQHHHH HH Biological Activity The ED50 is <2 μg/mL as measured by FDC-P1 cells. Appearance Lyophilized powder. Formulation Lyophilized after extensive dialysis against PBS. Endotoxin Level <0.2 EU/μg, determined by LAL method. Reconstitution Reconstitute the lyophilized recombinant Human Insulin-like growth factor-binding protein 2, His (HEK-expressed) (rHuIGF-BP-2, His) to 100 μg/mL using ddH2O or diluted with PBS. Storage & Stability Lyophilized recombinant Human Insulin-like growth factor-binding protein 2, His (HEK-expressed) (rHuIGF-BP-2, His) is stored at -20°C. After reconstitution, it is stable at 4°C for 1 week or -20°C for longer. It is recommended to freeze aliquots at -20°C or -80°C for extended storage. Shipping Room temperature in continental US; may vary elsewhere. Background Insulin-like Growth Factor Binding Protein 2 (IGFBP2) is a member of the family of high-affinity binding proteins (IGFBP1-6) and appears to play a governing role in Insulin-like Growth Factor (IGF) regulation in the central nervous system[1]. Insulin-like Growth Factor-Binding Proteins (IGFBPs) modulate the actions of secreted insulin-like growth facts (IGFs) by binding to them and increase the IGF halflife in the extracellular milieu and circulation by sequestering them in this bound form. IGFBPs either enhance or inhibit IGF actions on target cells; the individual IGFBPs either inhibit or potentiate IGF effects on osteoblasts in bone. Human Insulin-like Growth Factor-Binding Protein 5 (rhIGFBP-5) is a unique and most abundant IGFBP stored in bone, having a high specific binding affinity for hydroxyapatite and extracellular matrix proteins, therefore fixing it and its bound IGFs within bone. rhIGFBP-5 consistently stimulates osteoblast cell proliferation in vitro, thus increasing the number of osteoblasts[2]. |
| 貯存 |
- Recombinant Rat GRO alpha/CXCL1 (HEK293-expressed)
- Recombinant Human Heregulin-1 beta1
- Recombinant Human HVEM, Fc Chimera (Sf9 insect cells-expressed)
- Recombinant Human IFN-gamma Receptor II (CHO-expressed)
- Recombinant Human Insulin-like growth factor-binding protein 2, His (HEK-expressed)
- Recombinant Human Insulin-like growth factor-binding protein 4, His (HEK-expressed)
- Recombinant Rat Interleukin-12 (CHO-expressed)
- Recombinant Human Interleukin-15, His
- Recombinant Mouse Interleukin-17A (CHO-expressed)
滬公網(wǎng)安備 31012002003054號(hào)